Abstract
This study was designed to evaluate the prevalence and correlates of ED in a population of diabetic men. Consecutive patients with type 2 diabetes were recruited among outpatients regularly attending Diabetes Clinics. Inclusion criteria for the initial selection of patients were a diagnosis of type 2 diabetes for at least 6 months but less than 10 years, age 35–70 years, body mass index (BMI) of 24 or higher, HbA1c of 6.5% or higher: a total of 555 (90.8%) of the 611 men were analyzed in this study. ED was assessed by the IIEF-5 instrument. Approximately, 6 in 10 men in our sample of diabetic men had varying degrees of erectile dysfunction: mild 9%, mild to moderate 11.2%, moderate 16.9% and severe 22.9%. The prevalence of severe ED increased with age. Higher hemoglobin A1c (HbA1c) levels were associated with ED; similarly, the presence of metabolic syndrome, hypertension, atherogenic dyslipidemia (low levels of HDL-cholesterol and high levels of triglycerides) and depression was associated with ED. Physical activity was protective of ED; men with higher levels of physical activity were 10% less likely to have ED as compared with those with the lowest level. In conclusion, among subjects with type 2 diabetes glycemic control and other metabolic covariates were associated with ED risk, whereas higher level of physical activity was protective. These results encourage the implementation of current medical guidelines that place intensive lifestyle changes as the first step of the management of type 2 diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
NIH Consensus Conference. Impotence NIH consensus development panel on impotence. JAMA 1993; 270: 83–90.
Malavige LS, Levy JC . Erectile dysfunction in diabetes mellitus. J Sex Med 2009; 6: 1232–1247.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinley JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994; 151: 54–61.
Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB . Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massacusetts male aging study. J Urol 2000; 163: 460–463.
Penson DF, Latini DM, Lubek DP, Wallace KL, Henning JM, Lue TF . Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) Database. Diabetes Care 2003; 26: 1093–1099.
Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA . Oral sildenafil in the treatment of erectile dysfunction: Sildenafil study group. N Engl J Med 1998; 338: 1397–1404.
Eardley I, Fisher W, Rosen RC, Niederberger C, Nadel A, Sand M . The multinational men's attitudes to life events and sexuality study: the influence of diabetes on self-reported erectile function, attitudes and treatment seeking patterns in men with erectile dysfunction. Int J Clin Pract 2007; 61: 1446–1453.
Hidalgo-Tamola J, Chitaley K . Type 2 diabetes mellitus and erectile dysfunction. J Sex Med 2009; 6: 916–926.
Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E et al. Erectile dysfunction in diabetic subjects in Italy. Diabetes Care 1998; 21: 1973–1977.
Romeo JH, Seftel AD, Madhum ZT, Aron DC . Sexual function in men with diabetes type 2: association with glycemic control. J Urol 2000; 163: 788–791.
De Angelis L, Marfella R, Siniscalchi M, Marino L, Nappo F, Giugliano F et al. Erectile and endothelial dysfunction in type II diabetes: a possible link. Diabetologia 2001; 44: 1155–1160.
Zheng H, Fan W, Li G, Tam T . Predictors for erectile dysfunction among diabetics. Diabetes Res Clin Pract 2006; 71: 313–319.
Shiri R, Ansari M, Falah Hassani K . Association between comorbidity and erectile dysfunction in patients with diabetes. Int J Impot Res 2006; 18: 348–353.
Al-Hunayan A, Al. Mutar M, Kehinde EO, Thalib L, Al-ghorory M . The prevalence and predictors of erectile dysfunction in men with newly diagnosed type 2 diabetes mellitus. BIU Int 2007; 99: 130–134.
Seftel AD, Sun P, Swindle R . The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004; 171: 2341–2345.
Esposito K, Giugliano F, Ciotola M, De Sio M, D'Armiento M, Giugliano D . Obesity and sexual dysfunction, male and female. Int J Impot Res 2008; 20: 358–365.
Esposito K, Giugliano D, Nappo F, Marfella R . Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004; 110: 214–219.
Esposito K, Ciotola M, Carleo D, Schisano B, Sardelli L, Di Tommaso D et al. Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 1345–1350.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.
Cappelleri JC, Rosen RC . The sexual health inventory for men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307–319.
Expert Panel on Detection Evaluation Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486–2497.
Grundy SM . Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone 2006; 8 (1): S21–S27.
IPAQ Research Committee. Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ). International Physical Activity Questionnaire. Available at http://www.ipaq.ki.se. Last accessed 20 October 2009.
Wing RR, Rosen RC, Fava JL, Bahnson J, Brancati F, Gendrano III IN et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the look AHEAD trial. J Sex Med 2009; 6: 1414–1422.
Cho NH, Ahn CW, Park JY, Ahn TY, Lee HW, Park TS et al. Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus. Diabet Med 2006; 23: 198–203.
Thomas GN, Tomlinson B, Abdullah AS, Yeung VT, Chan JC, Wong KS . Association of erectile dysfunction with cardiovascular risk factors and increasing existing vascular disease in male chinese type 2 diabetic patients. Diabetes Care 2005; 28: 2051–2053.
Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y et al. Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res Clin Pract 2005; 70: 81–89.
Lu CC, Jiann BP, Sun CC, Lam HC, Chu CH, Lee JK . Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med 2009; 6: 1719–1728.
Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN . Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994; 140: 930–937.
Esposito K, Giugliano F, Marted E, Feola G, Marfella R, D'Armiento M et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 2005; 28: 1201–1203.
Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB . Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–306.
Cheng JYW, Ng EML, Chen RYL . Physical activity and erectile dysfunction: meta-analysis of population-based studies. Int J Impot Res 2007; 19: 245–252.
Rosen RC, Wing R, Schneider S, Gendrano IIIN . Epidemiology of erectile dysfunction. The Role of Medical Comorbidities and Lifestyle Factors. Urol Clin North Am 2005; 32: 403–417.
Esposito K, Ciotola M, Giugliano F, Maiorino MI, Autorino R, De Sio M et al. Effects of intensive lifestyle changes on erectile dysfunction in men. J Sex Med 2009; 6: 243–250.
Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978–2984.
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American diabetes association and the European association for the study of diabetes. Diabetes Care 2009; 32: 193–203.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Giugliano, F., Maiorino, M., Bellastella, G. et al. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res 22, 204–209 (2010). https://doi.org/10.1038/ijir.2010.1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2010.1
Keywords
This article is cited by
-
Erectile Dysfunction and Associated Factors in Men with Type 2 Diabetes Mellitus
Sexuality and Disability (2024)
-
Semen quality and metabolic profile in people with type 1 diabetes with and without erectile dysfunction: a cross-sectional study
Journal of Endocrinological Investigation (2024)
-
Effects of ozone treatment on penile erection capacity and nitric oxide synthase levels in diabetic rats
International Journal of Impotence Research (2021)
-
Sexual dysfunctions and short-term glucose variability in young men with type 1 diabetes
Hormones (2021)
-
The Experience of Indonesian Men Living with Type-2 Diabetes Mellitus and Erectile Dysfunction: A Semi-structured Interview Study
Sexuality and Disability (2021)